Jennifer K. Moses
2019
In 2019, Jennifer K. Moses earned a total compensation of $1.4M as Chief Financial Officer at G1 Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $117,600 |
|---|---|
| Option Awards | $972,601 |
| Salary | $315,598 |
| Other | $8,400 |
| Total | $1,414,199 |
Moses received $972.6K in option awards, accounting for 69% of the total pay in 2019.
Moses also received $117.6K in non-equity incentive plan, $315.6K in salary and $8.4K in other compensation.
Rankings
In 2019, Jennifer K. Moses' compensation ranked 7,609th out of 13,971 executives tracked by ExecPay. In other words, Moses earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,609 out of 13,971 | 46th |
Division Manufacturing | 2,964 out of 5,701 | 48th |
Major group Chemicals And Allied Products | 1,115 out of 2,200 | 49th |
Industry group Drugs | 949 out of 1,886 | 50th |
Industry Pharmaceutical Preparations | 703 out of 1,398 | 50th |
Pay ratio
| Jennifer K. Moses' Pay | $1,414,199 |
|---|---|
| Median Employee's Pay | $213,060 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Jennifer K. Moses was $1,414,199.
The annual total compensation of the median employee at G1 Therapeutics was $213,060.
The ratio of Jennifer K. Moses' pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 24, 2020.
Moses' colleagues
We found five more compensation records of executives who worked with Jennifer K. Moses at G1 Therapeutics in 2019.